UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033162
Receipt number R000037822
Scientific Title Analysis of pathology of locomotive disorder and application of synovial mesenchymal stem cells for regenerative medicine
Date of disclosure of the study information 2018/06/29
Last modified on 2019/03/31 22:46:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of pathology of locomotive disorder and application of synovial mesenchymal stem cells for regenerative medicine

Acronym

Study of synovial mesenchymal stem cells and its application for regenerative medicine

Scientific Title

Analysis of pathology of locomotive disorder and application of synovial mesenchymal stem cells for regenerative medicine

Scientific Title:Acronym

Study of synovial mesenchymal stem cells and its application for regenerative medicine

Region

Japan


Condition

Condition

locomotive disorder

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

Transfer of the established technique to the external faculty for efficient proliferation of synovial mesenchymal stem cells under human serum.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Proliferative property of synovial mesenchymal stem cells under volunteers' serum.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Medicine

Interventions/Control_1

Serum is extracted from volunteer's blood, and synovial mesenchymal stem cells are cultured by using it.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

Healthy adult volunteers with no remarkable medical record and afford to undergo blood sampling as much as 300ml.

Key exclusion criteria

Anemic patients

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Ichiro
Middle name
Last name Sekiya

Organization

Tokyo Medical and Dental University

Division name

Center of Stem Cell and Regenerative Medicine

Zip code

113-8519

Address

1-5-45 Yushima, Bunkyo-ku, Tokyo

TEL

0358034017

Email

sekiya.arm@tmd.ac.jp


Public contact

Name of contact person

1st name Office administrator
Middle name
Last name Office administrator

Organization

Tokyo Medical and Dental University

Division name

Center of Stem Cell and Regenerative Medicine

Zip code

113-8519

Address

1-5-45 Yushima, Bunkyo-ku, Tokyo

TEL

0358034017

Homepage URL


Email

saisei01.arm@tmd.ac.jp


Sponsor or person

Institute

Tokyo Medical and Dental University

Institute

Department

Personal name



Funding Source

Organization

Japanese Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB for TMDU

Address

1-5-45 Yushima, Bunkyo-ku, Tokyo

Tel

0358036111

Email

info.bec@tmd.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 06 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2018 Year 06 Month 29 Day

Date of IRB

2017 Year 10 Month 31 Day

Anticipated trial start date

2018 Year 08 Month 01 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 06 Month 27 Day

Last modified on

2019 Year 03 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037822


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name